Delivery Order SPE2DB20D1004-SPE2DB23FE8H8
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,407.52 for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 21, 2023. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,903.98 for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 9, 2022. The contract utilizes a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,046.76 for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS medication. The contract, awarded by the Defense Logistics Agency (DLA), has a completion date of December 18, 2023. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,174.44 firm-fixed-price delivery order is for the pharmaceutical product HUMIRA PEN 40 MG/0.8 MLS. The contract has an ultimate completion date of September 20, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order with a ceiling value of $7,391.94 for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract was awarded on February 7, 2023, with a completion date of February 8, 2023. The contracting agency is the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $10,986.97 for the pharmaceutical product Humira(CF) Pen 40 mg/0.4 mls. The award was made by the Defense Logistics Agency (DLA), a defense agency, on December 26, 2023, with a completion date of December 27, 2023. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) to provide HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The firm-fixed-price delivery order, valued at $2,348.88, has a completion date of March 20, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $4,732.88 for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 6, 2023. This is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $13,383.47 for the supply of HUMIRA PEN 40 MG/0.8 MLS pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 29, 2024. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $5,357.76 for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 10, 2021. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued at up to $999,999,999.00, and...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB23FE8H8Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,469.24 for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on November 7, 2022, with a completion date of November 8, 2022. The contract is a Firm Fixed Price arrangement without any set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/7/22 |